LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis

Journal of Rheumatology

Volumn 27, Issue 1, 2000, Pages 183-189

  Maksymowych, Walter P ^a   Sha, Tao ^b   Vaile, Jan ^b   Suarez Almazor, Maria ^b   Ramos Remus, Cesar ^b   Russell, Anthony S ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

Ankylosing spondylitis; HLA B27 negative; LMP2 polymorphism

Indexed keywords

HLA B27 ANTIGEN;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNIC GROUP; GENETIC POLYMORPHISM; GENOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RHEUMATIC DISEASE;

ADULT; AGED; ALLELES; CONTINENTAL POPULATION GROUPS; CYSTEINE ENDOPEPTIDASES; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEXICO; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEINS; SPONDYLITIS, ANKYLOSING;

EID: 0342470536     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Khan MA, Kellner H. Immunogenetics of spondyloarthropathies. Rheum Dis Clin North Am 1922;18:837-64.
2. Khan MA, Kushner I, Braun WE. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 1977;20:909-12.
3. Linsen A, Feltkamp TEW. B27 positive disease versus B27 negative diseases. Ann Rheum Dis 1988;47:431-9.
4. Arnett FC, Hochberg MC. Bias WB. Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis. Johns Hopkins Med J 1977;141:193-7.
5. Khan MA. B7-CREG and ankylosing spondylitis. Br J Rheumatol 1983;22 Suppl: 129-33.
6. Khan MA, Kushner I, Braun WE. A subgroup of ankylosing spondylitis associated with HLA-B7 in American blacks. Arthritis Rheum 1978;21:528-30.
7. Wagener P. Zeidler H, Eckert G. et al. Increased frequency of HLA-Bw62 and Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis. J Rheumatol 1984;43:253-7.
8. Mielants H, Veys EM, Joos R, Noens L. Cuvelier C, De Vos M. HLA antigens in seronegative spondyloarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. J Rheumatol 1987;14:466-71.
9. Van den Berg-Loonen EM, Dekker-Saeys BJ, Meuwissen SGM, et al. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel disease. J Immunogenet 1997;4:167-75.
10. Khan MA, Kushner I, Braun WE. Genetic heterogeneity in primary ankylosing spondylitis. J Rheumatol 1980;7:383-6.
11. Gladman DD, Anhorn KAB, Schachter RK, et al. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
12. Yamaguchi A, Tsuchiya N, Mitsue H, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Arthritis Rheum 1995;38:1672-7.
13. Brown M, Bunce M, Calin A, Darke C, Wordsworth P. HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi, et al [letter]. Arthritis Rheum 1996;39:1768-9.
14. Brown MA, Pike KD, Kennedy LG, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
15. Falk K, Rotzschke O, Takiguchi M, et al. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 1995;41:162-4.
16. Maksymowych WP, Chou C, Russell AS. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis 1995;54:128-30.
17. Lehtinen K. Seventy six patients with ankylosing spondylitis seen after 30 years of disease. Scand J Rheumatol 1983;12:5-11.
18. Maksymowych WP, Suarez-Almazor M, Chou C, Russell AS. Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann Rheum Dis 1995;54:321-4.
19. Glynne R, Powis SH, Beck S, Kelly A, Kerr L, Trowsdale J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC, Nature 1991;353:357-60.
20. Goldberg AL, Rock KL. Proteolysis, proteasomes, and antigen presentation. Nature 1992;357:375-9.
21. Fruh K, Gossen M, Wang K, Byard H, Peterson PA, Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 1994;13:3236-44.
22. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994;1:533-41.
23. Hohler T, Schaper T, Schneider PM, et al. No primary association between LMP2 polymorphisms and extraspinal manifestations in spondyloarthropathies. Ann Rheum Dis 1997;56:741-3.
24. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
25. Gorodezky C. Genetic differences between Europeans and Indians: tissue and blood types. Allergy Proc 1992;13:243-50.
26. Van Enden PM, Liblau RS, Patel SD, et al. Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 1994;43:110-7.
27. Djilali-Saiah I. Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 1996;48:87-92.
28. Burney RO, Pile KD, Gibson K, et al. Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994;53:58-60.
29. Van Endert PM, Lopez MT, Patel SD, Monaco JJ, McDevitt HO. Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes. Proc Natl Acad Sci USA 1992;89:11594-7.
30. Maksymowych WP. No primary association between LMP2 polymorphisms and extraspinal manifestations in spondyloarthropathies: comment on article by Hohler, et al. Ann Rheum Dis 1999;58:386.
31. Koskimies S, Westman P, Jarvinen P, Leirisalo-Repo M. Different extended MHC haplotypes associated to uncomplicated and complicated spondyloarthropathies [abstract]. J Rheumatol 1998;25 Suppl 54:27.
32. Brown MA, Kennedy LG, Darke C, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998;41:460-5.
33. Maksymowych WP, Jhangri GS, Gorodezky C, et al. The LMP2A allele is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican individuals with ankylosing spondylitis. Ann Rheum Dis 1997;56:488-92.
34. Boyer GS, Templin DW, Bowler A, et al. Class I HLA antigens in spondyloarthropathy: observations in Alaskan Eskimo patients and controls. J Rheumatol 1997;24:500-6.
35. Vargas-Alarcon G, Garcia A, Bahena S, et al. HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies. Ann Rheum Dis 1994;53:755-8.
36. Awada H, Baddoura R, Naman R, et al. Weak association between HLA-B27 and the spondyloarthropathies in Lebanon. Arthritis Rheum 1997;40:388-90.
37. Robinson WP, van der Linden S, Khan MA, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27 positive patients. Arthritis Rheum 1989;32:1135-41.
38. Calin A, Brophy S, Kennedy LG, Brown M, Wordsworth P. The role of B60 in disease expression of ankylosing spondylitis [abstract]. Arthritis Rheum 1997;40 Suppl:1083.
39. Maksymowych WP, Gorodezky C, Olivo A, et al. HLA-DRB1* 08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol 1997;24:904-7.